The BioMed X Institute
German research institute BioMed X and Ono Pharmaceutical, a Japanese pharmaceutical company, started a new joint research project on cancer immunotherapies.
HEIDELBERG, GERMANY / ACCESSWIRE / December 19, 2023 / BioMed X announced today a new joint research project with Ono Pharmaceutical Co., Ltd, marking the start of the collaboration between the German biomedical research institute and one of the largest pharmaceutical companies in Japan. The project entitled "New Strategies to Engage Neutrophils in Solid Tumors" will be hosted by the BioMed X Institute in Heidelberg, Germany. The goal of this research project is to design next-generation immunotherapies by leveraging the antitumor effects of neutrophils.
Developing immunotherapies that target T cells has proved highly effective, and it is still a rapidly evolving research area. However, many patients remain resistant to these therapies, necessitating the development of novel immunological strategies. The presence of neutrophils in solid tumors has been well-documented, albeit their role in the tumor microenvironment seems to be paradoxical according to the data accumulated thus far. By uncovering novel neutrophil biology, this project aims to leverage their functions to design novel immunotherapies.
The new research team will join nine other research groups at the BioMed X Institute in Heidelberg, Germany. Researchers who are interested in becoming part of this new research group are invited to respond to this international call for application by submitting a project proposal via the BioMed X Career Space at https://career.bio.mx/call/2023-BMX-C03 before February 18, 2024.
Christian Tidona, Founder and Managing Director of the BioMed X Institute: "Oncology and immunology, including tumor immunology, are key areas of expertise at BioMed X. We are proud and honored that Ono has chosen our institute to develop new strategies for engaging neutrophils in cancer therapy".
Toichi Takino, Senior Executive Officer/Executive Director, Discovery & Research at Ono Pharmaceutical: "We are very pleased to form a partnership with BioMed X in our mission dedicated to overcoming cancer. This innovative research collaboration will engage us with highly talented scientists around the world who possess unique ideas for immunotherapy utilizing neutrophils. We believe that the research team established through this collaboration will lead to the discovery of the next generation of immunotherapy with us".
About BioMed X
BioMed X is an independent research institute with sites in Heidelberg, Germany, New Haven, Connecticut, XSeed Labs in Ridgefield, Connecticut, and a worldwide network of partner locations. Together with our partners, we identify big biomedical research challenges and provide creative solutions by combining global crowdsourcing with local incubation of the world's brightest early-career research talents. Each of the highly diverse research teams at BioMed X has access to state-of-the-art research infrastructure and is continuously guided by experienced mentors from academia and industry. At BioMed X, we combine the best of two worlds - academia and industry - and enable breakthrough innovation by making biomedical research more efficient, more agile, and more fun.
About Ono
Ono Pharmaceutical Co., Ltd., headquartered in Osaka, Japan, is an R&D-oriented pharmaceutical company committed to creating innovative medicines in specific areas. Ono focuses its research on oncology, immunology, neurology and specialty research with high medical needs as priority areas for discovery and development of innovative medicines. For further information, please visit the company's website at https://www.ono-pharma.com/en.
Contact Information
Flavia-Bianca Cristian
Recruiting & Communications Manager
fbc@bio.mx
+49 6221 426 11 706
View the original press release on newswire.com.
SOURCE: BioMed X Institute
To view this piece of content from stats.newswire.com, please give your consent at the top of this page. To view this piece of content from www.accesswire.com, please give your consent at the top of this page.About ACCESSWIRE
Subscribe to releases from ACCESSWIRE
Subscribe to all the latest releases from ACCESSWIRE by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESSWIRE
Tonogold Posts Presentation Detailing the JAG Minerals Acquisition3.10.2024 09:00:00 CEST | Press release
Highlights TONOGOLD highlights the historic, low risk districts of uranium and vanadium production close to existing mineral production and processing. The Company will seek to accelerate the exploration, development and production of these critically important minerals. WOODLAND HILLS, CA / ACCESSWIRE / October 3, 2024 / TONOGOLD Resources Inc. (OTC PINK:TNGL) ("TONOGOLD" or the "Company") is pleased to inform shareholders that it has posted a presentation on its website detailing the previously announced acquisition of JAG Minerals Pty Ltd. This acquisition is the culmination of 12 months of work by both the TONOGOLD and JAG teams and, TONOGOLD believes, will lead to a leader in the uranium industry. The presentation can be accessed via this link: https://tonogold.com/corporate/presentation/ TONOGOLD CEO William Hunter stated: "We're pleased to be moving this transaction forward and look forward to operating these assets upon closing. The strategic importance of nuclear power in an i
New Preservica Application Drives Greater Efficiency and Transparency for UK Local Government Records3.10.2024 04:00:00 CEST | Press release
OXFORD, UK / ACCESSWIRE / October 3, 2024 / Preservica, a recognized leader in Active Digital Preservation™, has launched a new edition of its popular archiving software that's purpose-designed to enable UK Local Authority record-keeping teams to more efficiently maintain reliable, complete and retrievable long-term and permanent digital records in alignment with their obligations under the UK Public Records Act, Freedom of Information Act (FOIA) and UK GDPR (General Data Protection Regulation). Speed, automation and more efficient services Developed in collaboration with its community of nearly 50 UK local authority Records Offices and Archives, the new Preservica UK Local Government edition comes ready-configured with folders, metadata and workflows to enable record-keeping teams to rapidly create a trusted repository for managing and protecting many different types of long-term government records and digital formats including: Democratic Services - Councils and Committees Adult & Ch
Sama CEO Wendy Gonzalez to Speak at CogX Leadership Summit on AI3.10.2024 03:00:00 CEST | Press release
Gonzalez to discuss how to deploy responsible AI across an organization, and the importance of diverse leadership in fostering AI innovation and improving bottom line performance LONDON, UNITED KINGDOM / ACCESSWIRE / October 3, 2024 / Sama, the leader in purpose-built, responsible enterprise AI with agile data labeling for model development and supervised fine-tuning, today announced that CEO Wendy Gonzalez will speak in two separate sessions at the upcoming CogX Leadership Summit on AI, taking place in London on October 7, 2024. In her first session of the conference, slated for 12 noon in the Prince of Wales room, Gonzalez will join Gopal Ramchurn of Responsible AI UK and Nia Castelly, co-founder and head of legal at Checks, Google's AI-powered platform that helps developers build safer products by simplifying privacy compliance. Entitled Demystifying Responsible AI: A Guide for Leaders, this panel will explore the challenges, opportunities, regulatory considerations and strategies n
FINOS Releases First Draft of AI Governance Framework for Financial Institutions at OSFF NY with a Groundswell of Support from Industry Leaders1.10.2024 10:30:00 CEST | Press release
New FINOS Platinum Members include NVIDIA and Protect AI with Moody's joining as a Gold Member, alongside key financial services and AI industry leaders. NEW YORK, NY / ACCESSWIRE / October 1, 2024 / The Fintech Open Source Foundation (FINOS), the financial services umbrella of the Linux Foundation, proudly announced multiple Artificial Intelligence (AI) milestones at this week's Open Source in Finance Forum New York (OSFF NY). These developments include the draft release of a groundbreaking AI Governance Framework for financial institutions from the FINOS AI Readiness Special Interest Group (SIG) and an invitation to the broader community to participate in this now fully open initiative. Additionally, the broader FINOS AI initiative has been embraced by an impressive list of financial services and technology organizations and is attracting new members who are leaders in AI, including NVIDIA, Protect AI, and Moody's. "It's exciting to see how the FINOS membership has come together in a
Graid Technology Inc. and KLC Group Forge Groundbreaking Partnership to Redefine High-Speed RAID and Data-at-Rest Security1.10.2024 10:00:00 CEST | Press release
Protecting enterprise and military servers with unmatched NVMe RAID performance and the most advanced cybersecurity encryption on the market. SANTA CLARA, CA / ACCESSWIRE / October 1, 2024 / As data demands surge in today's hyper-competitive landscape, organizations are constantly seeking solutions that balance cutting-edge security with uncompromised performance. A new strategic partnership between Graid Technology, creators of SupremeRAID™, and KLC Group, innovators behind CipherDriveOne Plus, is set to redefine this balance with a first-of-its-kind solution for high-speed storage and NSA CSfC-certified Data-at-Rest (DAR) Security. Graid Technology Inc. and KLC Group Secure Groundbreaking Partnership to Disrupt High-Speed RAID and Data-at-Rest Security At the core of this collaboration is a novel approach to data security. Combining the National Security Agency's (NSA) Commercial Solutions for Classified (CSfC) Data-at-Rest (DAR) Security guidelines, the joint solution integrates enc
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom